Diagnosing and treating premenstrual syndrome in five western nations

Social Science and Medicine

Volumn 68, Issue 8, 2009, Pages 1498-1505

  Weisz, George ^a   Knaapen, Loes ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Canada; France; Germany; Medicalization; Premenstrual dysphoric disorder; Premenstrual syndrome; UK; USA

Indexed keywords

ANALGESIC AGENT; HORMONE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; VITAMIN; VITEX AGNUS CASTUS EXTRACT;

DATABASE; DISEASE TREATMENT; DRUG; GUIDELINE; HEALTH CARE; LANGUAGE; PSYCHOLOGY; REPRODUCTIVE CYCLE; WOMENS HEALTH;

ARTICLE; CONSULTATION; CONTROLLED STUDY; FEMALE; FRANCE; GERMANY; HUMAN; MEDICAL INFORMATION SYSTEM; MEDICAL PRACTICE; MEDICAL RESEARCH; NORTH AMERICA; PRACTICE GUIDELINE; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; UNITED KINGDOM; UNITED STATES;

CANADA; COMPLEMENTARY THERAPIES; FEMALE; FRANCE; GERMANY; GREAT BRITAIN; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PREMENSTRUAL SYNDROME; PREVALENCE; UNITED STATES;

CENTRAL EUROPE; EURASIA; EUROPE; FRANCE; GERMANY; NORTH AMERICA; UNITED KINGDOM; WESTERN EUROPE;

VITEX AGNUS-CASTUS;

EID: 63149152716     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2009.01.036     Document Type: Article

References (76)

1. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 15 Premenstrual Syndrome (2000), American College of Obstetrics and Gynecology, Washington, D.C., USA
2. Adler P.A., and Adler P. The demedicalization of self-injury: from psychopathology to sociological deviance. Journal of Contemporary Ethnography 36 5 (2007) 537-570
3. Angst J., Sellaro R., Merikangas K.R., and Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatrica Scandinavica 104 2 (2001) 110-116
4. Bhatia S.C., and Bhatia S.K. Diagnosis and treatment of premenstrual dysphoric disorder. American Family Physician 66 (2002) 1239-1248
5. Campbell E.M., Peterkin D., O'Grady K., and Sanson-Fisher R. Premenstrual symptoms in general practice patient: prevalence and treatment. The Journal of Reproductive Medicine 42 10 (1997) 637-646
6. Caplan P.J., McCurdy-Myers J., and Gans M. Should "premenstrual syndrome" be called a psychiatric abnormality?. Feminism & Psychology 2 (1992) 27-44
7. Chakmakjian Z.H. A critical assessment of therapy for the pre-menstrual tension syndrome. The Journal of Reproductive Medicine 28 (1983) 532-538
8. Choi P.Y.L. Premenstrual syndrome? Introduction. Social Science & Medicine 41 6 (1995) 759-760
9. Cohen L., Soares C., Otto M., Sweeney B., Liberman R., and Harlow B. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. Journal of Affective Disorders 70 2 (2002) 125-132
10. Dalton K. The premenstrual syndrome (1964), C.C. Thomas, Springfield, IL
11. Dalton K. The premenstrual syndrome and progesterone therapy (1977), William Heinemann Medical Books, London
12. Dalton K. Cyclical criminal acts in premenstrual syndrome. The Lancet 2 8203 (1980) 1070-1071
13. Deuster P.A., Adera T., and South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Archives of Family Medicine 8 2 (1999) 122-128
14. Dickerson L.M., Mazyck P.J., and Hunter M.H. Premenstrual syndrome. American Family Physician 67 (2003) 1743-1752
15. Fenton C., Wellington K., Moen M.D., and Robinson D.M. Drospirenone/ethinylestradiol 3 mg/20 μg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris. Drugs 67 12 (2007) 1749-1765
16. Figert A.E. Women and the ownership of PMS: The structuring of a psychiatric disorder (1996), Aldine de Gruyter, Hawthorne, NY, USA
17. Ford O., Lethaby A., Mol B., and Roberts H. Progesterone for premenstrual syndrome. Cochrane Database of Systematic Reviews 4 (2006) CD003415 Retrieved May 1 2008
18. Frank R.T. The hormonal basis of premenstrual tension. Archives of Neurological Psychiatry 26 (1931) 1053-1057
19. Freeman E.W. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. The European Journal of Contraception & Reproductive Health Care 7 Suppl. 3 (2002) 27-34 discussion 42-23
20. Gehlert S., Song I.H., Chang C.H., and Hartlage S.A. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychological Medicine (2008) 1-8
21. Gold J.H., and Severino S.K. Premenstrual dysphorias. Myths and realities (1994), American Psychiatric Press Inc., Washington, D.C., USA
22. Halbreich U. Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough. CNS Spectrums 13 (2008) 566-572
23. Halbreich U., Borenstein J., Pearlstein T., and Kahn L.S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28 Suppl. 3 (2003) 1-23
24. Horney K. Die prämenstruellen Verstimmungen. Zeitschrift für Psychoanalytische Pädagogik 5 (1931) 1-7
25. Hurt S.W., Schnurr P.P., Severino S.K., Freeman E.W., Gise L., Rivera-Tovar A., et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. American Journal of Psychiatry 149 4 (1992) 525-530
26. Hylan T., Sundell K., and Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. Journal of Women's Health & Gender-Based Medicine 8 (1999) 1043-1052
27. Johnson S.R. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstetrics and Gynecology 104 (2004) 845-859
28. Johnson T.M. Premenstrual syndrome as a western culture-specific disorder. Culture, Medicine & Psychiatry 11 (1987) 337-356
29. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., and Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine (2008) Retrieved on 2008-02-26
30. Knaapen L., and Weisz G. The biomedical standardization of premenstrual syndrome. Studies in History and Philosophy of Biological and Biomedical Sciences 39 (2008) 120-134
31. Laws S. The sexual politics of premenstrual tension. Women's Studies International Forum 6 (1983) 19-31
32. Lock M.M. Encounters with aging: Mythologies of menopause in Japan and North America (1993), University of California Press, Berkeley
33. Loder E.W. Menstrual migraine: pathophysiology, diagnosis, and impact. Headache 46 Suppl. 2 (2006) S55-S60
34. Lopez L.M., Kaptein A., and Helmerhorst F.M. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews 1 (2008) CD006586
35. Löwy I., and Weisz G. French hormones: progestins and therapeutic variation in France. Social Science & Medicine 60 11 (2005) 2609-2622
36. Martin E. The woman in the body: A cultural analysis of reproduction (1987), Beacon, Boston
37. Mullan F. Wrestling with variation: an interview with Jack Wennberg. Health Affairs (2004). Web exclusive http://content.healthaffairs.org/webexclusives/index.dtl?year=2004 Accessed 06.09.07
38. Nicolson P. The menstrual cycle, science and femininity: assumptions underlying menstrual cycle research. Social Science & Medicine 41 6 (1995) 779-784
39. Observatoire de la médecine générale. Observatoire de la médecine générale 2006-4 (2006), Société Française de Médecine Générale. http//:omg.sfmg.org Consulted June 13 2008
40. Parlee M.B. Stereotypic beliefs about menstruation: a methodological note on the Moos Menstrual Distress Questionnaire and some new data. Psychosomatic Medicine 36 3 (1974) 229-240
41. Pearlstein T., and Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. Journal of Psychiatry and Neuroscience 33 4 (2008) 291-301
42. Ramcharan S., Love E.J., Fick G.H., and Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors. Journal of Clinical Epidemiology 45 4 (1992) 377-392
43. Richardson J.T.E. The premenstrual syndrome: a brief history. Social Science & Medicine 41 6 (1995) 761-767
44. Riessman C. Women and medicalisation: a new perspective. Social Policy 14 1 (1983) 3-18
45. Rittenhouse C.A. The emergence of premenstrual-syndrome as a social-problem. Social Problems 38 3 (1991) 412-425
46. Rivera-Tovar A.D., and Frank E. Late luteal phase dysphoric disorder in young women. American Journal of Psychiatry 147 12 (1990) 1634-1636
47. Rodin M. The social construction of premenstrual syndrome. Social Science & Medicine 35 (1992) 49-56
48. Ruble D.N., and Brooks-Gunn J. Menstrual symptoms: a social cognition analysis. Journal of Behavioral Medicine 2 (1979) 171-194
49. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ 322 7279 (2001) 134-137
50. Shah N.R., Jones J.B., Aperi J., Shemtov R., Karne A., and Borenstein J. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstetrics and Gynecology 111 5 (2008) 1175-1182
51. Singh B., Berman B., Simpson R., and Annechild A. Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Alternative Therapies in Health and Medicine 4 3 (1998) 75-79
52. Steiner M., Macdougall M., and Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women's Mental Health 6 3 (2003) 203-209
53. Sternfeld B., Swindle R., Chawla A., Long S., and Kennedy S. Severity of premenstrual symptoms in a health maintenance organization population. Obstetrics and Gynecology 99 6 (2002) 1014-1024
54. Stolberg M. The monthly malady: a history of premenstrual suffering. Medical History 44 (2000) 301-322
55. Sveindottir H., and Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstetricia et Gynecologica Scandinavica 79 5 (2000) 405-413
56. Takeda T., Tasaka K., Sakata M., and Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Archives of Women's Mental Health 9 4 (2006) 209-212
57. Taylor D. From "It's All in Your Head " to "Taking Back the Month": premenstrual syndrome (PMS) research and the contributions of the Society for Menstrual Cycle Research. Sex Roles 54 5-6 (2006) 377-391
58. Thys-Jacobs S., Ceccarelli S., Bierman A., Weisman H., Cohen M.A., and Alvir J. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. Journal of General Internal Medicine 4 3 (1989) 183-189
59. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., and Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. The New England Journal of Medicine 358 3 (2008) 252-260
60. Ussher J.M. The role of premenstrual dysphoric disorder in the subjectification of women. Journal of Medical Humanities 24 (2003) 131-146
61. Walker A. Theory and methodology in premenstrual syndrome research. Social Science & Medicine 41 6 (1995) 793-800
62. Webster D.E., Lu J., Chen S.N., Farnsworth N.R., and Wang Z.J. Activation of the mu-opiate receptor by Vitex agnus-castus methanol extracts: implication for its use in PMS. Ethnopharmacol 106 2 (2006) 216-221
63. Weisz G. Divide and conquer: A comparative history of medical specialization (2006), Oxford University Press, New York/Oxford
64. Weisz G., Cambrosio A., Keating P., Knaapen L., Schlich T., and Tournay V.J. The emergence of clinical practice guidelines. The Milbank Quarterly 85 4 (2008) 691-727
65. Wikler D., and Wikler N.J. Turkey-baster babies: the demedicalization of artificial insemination. The Milbank Quarterly 69 1 (1991) 5-40
66. Williams S.J., and Calnan M. The 'limits' of medicalization? Modern medicine and the lay populace in 'late' modernity. Social Science & Medicine 42 (1996) 1609-1620
67. Wittchen H.U., Becker E., Lieb R., and Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine 32 1 (2002) 119-132
68. Women's Health in Primary Care. Evidence-based recommendations for managing the premenstrual syndrome. Retrieved on 14 July 2005 from (2000). http://www.womenshealthpc.com/tmissue.html
69. Wong I., and Murray M. The potential of UK clinical databases in enhancing paediatric medication research. British Journal of Clinical Pharmacology 59 6 (2005) 750-755
70. Woods N.F., Most A., and Dery G.K. Prevalence of perimenstrual symptoms. American Journal of Public Health 72 11 (1982) 1257-1264
71. Wyatt K.M., Dimmock P., Jones P., Obhrai M., and O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 323 7316 (2001) 776-780
72. Wyatt K.M., Dimmock P.W., Frischer M., Jones P.W., and O'Brien S.P. Prescribing patterns in premenstrual syndrome. BMC Womens Health 2 1 (2002) 4
73. Wyatt K.M., Dimmock P.W., Jones P.W., and O'Brien P.M. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 318 7195 (1999) 1375-1381
74. Wyatt K.M., Dimmock P.W., and O'Brien P.M. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews 4 (2002) CD001396
75. Zola I.K. Culture and symptoms: an analysis of patients' presenting complaints. American Sociological Review 31 (1966) 615-630
76. Zola I.K. Pathways to the doctor: from person to patient. Social Science & Medicine 7 (1973) 677-689